Abstract
We read with great interest the publication by Lilly in a recent issue of Circulation .1 Lilly has provided a brief yet comprehensive review of the management of acute and recurrent pericarditis. Lilly has recommended that corticosteroids should never be used as a primary line of therapy in acute or recurrent idiopathic pericarditis, unless the disease symptoms are refractory to nonsteroidal anti-inflammatory drugs or colchicine. It is indeed true for the most practical purposes because the steroids have been shown to increase …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
